Yale University School of Medicine

Site:	Yale University School of Medicine
Address:	333 Cedar St
City:	New Haven
State:	CT
Zip:	06510
Country:	USA

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
1	A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors	Ongoing, but not recruiting	Closed	Cobimetinib + MPDL3280A	NCT01988896
3	A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT)	Recruiting	Active	Ripretinib	NCT05734105
1	A Study of the Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors That Are Non-Curable With Standard Therapy	Ongoing, but not recruiting	Closed	Sutent (Sunitinib, SU11248) + Sirolimus (Rapamycin, Rapamune)	NCT00402415
2	Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor	Completed	Closed	AUY922	NCT01404650
1	Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma	Ongoing, but not recruiting	Closed	PXD101	NCT00413075